GlassScriptPhysician profile
Snehalkumar Arjunbhai Patel
NPI 1043444789
$19,762.94
in general payments reported to CMS, 2019-2025
37 companies · $2,624 in 2025
The $2,624 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,691 · 2020: $4,344 · 2021: $1,615 · 2022: $1,034 · 2023: $1,266 · 2024: $7,190 · 2025: $2,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,881 · Travel and Lodging: $5,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,880.72 |
| Travel and Lodging | $5,199.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,257.19 | 2021-2025 | Corevalve Evolut R, Micra, Linq II |
| Medtronic Vascular, INC. | $3,794.91 | 2019-2020 | |
| Edwards Lifesciences Corporation | $2,801.14 | 2019-2024 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $1,559.89 | 2019-2025 | Cardiomems, Navitor |
| Boston Scientific Corporation | $1,552.97 | 2020-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System, Acuity Steerable |
| Novartis Pharmaceuticals Corporation | $481.66 | 2019-2025 | |
| Amgen INC. | $469.96 | 2019-2025 | Repatha, Repatha, Tavneos |
| Janssen Pharmaceuticals, INC | $432.81 | 2019-2024 | Xarelto |
| Abiomed | $268.20 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.42 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $176.29 | 2021-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.58 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $158.30 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $157.59 | 2019-2025 | Farxiga |
| Zoll Circulation INC | $144.01 | 2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $131.12 | 2019-2021 | |
| Philips North America LLC | $121.35 | 2022 | |
| Esperion Therapeutics, INC. | $116.61 | 2020-2022 | |
| Cardiva Medical, INC. | $107.68 | 2024-2025 | Savvywire |
| Pfizer INC. | $99.22 | 2022-2025 | |
| Bard Peripheral Vascular, INC. | $75.00 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $53.57 | 2024 | Arcalyst |
| Angiodynamics, INC. | $44.87 | 2024 | Auryon Laser System 100-120 Vac |
| Teleflex LLC | $44.63 | 2025 | Guideliner, Trapliner |
| Kiniksa Pharmaceuticals, LTD. | $44.47 | 2022-2023 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $43.18 | 2021-2023 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $41.54 | 2025 | |
| Tactile Systems Technology INC | $37.80 | 2021-2024 | Entre Plus, Flexitouch Plus |
| Imperative Care, INC | $35.94 | 2025 | Symphony Catheter |
| Novo Nordisk INC | $30.32 | 2020-2024 | |
| Lilly USA, LLC | $22.86 | 2025 | Zepbound, Mounjaro |
| Corindus INC. | $19.00 | 2019 | |
| Alnylam Pharmaceuticals INC. | $16.28 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.57 | 2022 | |
| Inari Medical, INC. | $13.55 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $13.39 | 2021 | |
| Cvrx, INC. | $8.07 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Snehalkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.